Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Consort Medical PLC

13 Jan 2020 11:38

RNS Number : 6169Z
Samson Rock Capital LLP
13 January 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

SAMSON ROCK CAPITAL LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

CONSORT MEDICAL PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

10/01/2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORDINARY 10p

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Cash-settled derivatives:

 

1,518,503

3.08

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

1,518,503

3.08

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

ORDINARY 10p

 

CFD

 

INCREASING A LONG POSITION

33

 

1,025 GBp

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

13/01/2020

Contact name:

ABEL ROMERO

Telephone number*:

02039941800

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETEAFFDFDXEEFA
Date   Source Headline
18th Jul 201410:21 amRNSDirector/PDMR Shareholding
16th Jul 20147:00 amRNSDirector/PDMR Shareholding
14th Jul 20147:00 amRNSDirectorate Change
1st Jul 20143:46 pmRNSTotal Voting Rights
26th Jun 201410:37 amRNSHolding(s) in Company
24th Jun 20144:15 pmRNSHolding(s) in Company
23rd Jun 20144:28 pmRNSDirector/PDMR Shareholding
23rd Jun 20144:23 pmRNSDirector/PDMR Shareholding
19th Jun 20142:42 pmRNSDirector/PDMR Shareholding
17th Jun 20147:00 amRNSFinal results for the year ended 30 April 2014
4th Jun 20147:00 amRNSDirector Declaration
2nd Jun 20143:16 pmRNSBlocklisting Interim Review
22nd May 20147:00 amRNSChange of Adviser
16th May 201410:39 amRNSHolding(s) in Company
13th May 20147:00 amRNSKing Systems Milestone Payment
14th Apr 20144:58 pmRNSBlocklisting Interim Review
3rd Apr 201411:15 amRNSHolding(s) in Company
1st Apr 20147:00 amRNSDirector Declaration
19th Mar 20147:00 amRNSInterim Management Statement
3rd Mar 20149:00 amRNSTotal Voting Rights
6th Feb 201410:24 amRNSHolding(s) in Company
5th Feb 20142:45 pmRNSHolding(s) in Company
3rd Feb 20147:00 amRNSFDA Approval of Development Programme
28th Jan 20149:43 amRNSHolding(s) in Company
3rd Jan 20149:15 amRNSTotal Voting Rights
31st Dec 20139:34 amRNSHolding(s) in Company
4th Dec 20137:00 amRNSInterim results for the six months to 31/10/13
2nd Dec 20134:15 pmRNSBlocklisting Interim Review
2nd Dec 20134:14 pmRNSTotal Voting Rights
28th Nov 20137:00 amRNSBespak Supply Contract Award
20th Nov 20131:37 pmRNSJefferies 2013 Global Healthcare Conference
15th Nov 20131:54 pmRNSDirector Declaration
4th Nov 20133:37 pmRNSHolding(s) in Company
1st Nov 20137:00 amRNSTotal Voting Rights
31st Oct 201312:21 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
14th Oct 20134:09 pmRNSBlocklisting Interim Review
14th Oct 20133:58 pmRNSHolding(s) in Company
11th Oct 201312:08 pmRNSHolding(s) in Company
10th Oct 20133:32 pmRNSHolding(s) in Company
30th Sep 20133:26 pmRNSTotal Voting Rights
27th Sep 201310:17 amRNSDirector/PDMR Shareholding
6th Sep 20131:51 pmRNSHolding(s) in Company
5th Sep 20131:39 pmRNSDirector/PDMR Shareholding
3rd Sep 201310:15 amRNSResult of AGM
2nd Sep 20137:00 amRNSInterim Management Statement
26th Jul 20132:52 pmRNSPosting of Annual Report and Notice of AGM
24th Jul 20132:43 pmRNSDirector/PDMR Shareholding
22nd Jul 20137:00 amRNSBespak development contract award
27th Jun 201312:27 pmRNSBlocklisting
25th Jun 20134:11 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.